Trial intelligence / Profile preview

Comparison of PRP, Prolotherapy, Corticosteroid, and Placebo for Partial-Thickness Rotator Cuff Tears

NCT07871695Phase 4Completed

Sponsor
Ankara Atatürk Sanatorium Training and Research Hospital
Start
Oct 2024
Primary completion
Jan 2026
Countries
1
01

Overview

A Phase 4 trial of platelet-rich plasma, dextrose, betamethasone in partial-thickness rotator cuff tear (PRCT), sponsored by Ankara Atatürk Sanatorium Training and Research Hospital. Started Oct 2024; status: completed.

02

Drugs

platelet-rich plasmadextrosebetamethasone
03

Conditions

partial-thickness rotator cuff tear (PRCT)

Beyond the preview

Go deeper on NCT07871695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07871695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call